Tag Archives: Dr. Mirjana Wollner
Rambam placed first in 2017 for obtaining funds for clinical trials investments from pharmaceutical companies. In this case, being first holds out promise of new discovery benefitting patients worldwide. A 2017 report on clinical studies by